Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter study

Summary: The systemic immune-inflammation index (SII), derived from platelet, neutrophil, and lymphocyte counts in peripheral blood, is linked to prognosis in several cancers. We evaluated whether changes in SII during neoadjuvant therapy could predict treatment outcomes in gastric cancer. A total o...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	iScience
المؤلفون الرئيسيون:	Hua-Long Zheng, Li-Li Shen, Chen-bin Lv, Jia Lin, Bin-bin Xu, Zhen Xue, Jun Lu, Zhi-Wei Zheng, Chang-Ming Huang, Jia-bin Wang, Chao-Hui Zheng
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2026-05-01
الموضوعات:	Oncology Therapeutics
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2589004226009879

مواد مشابهة

Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancer
حسب: Jun He, وآخرون
منشور في: (2025-06-01)

Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models
حسب: Zhi-Jie Li, وآخرون
منشور في: (2024-09-01)

The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma
حسب: Jinqiu Liu, وآخرون
منشور في: (2025-03-01)

STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy
حسب: Bandarigoda N. Somatilaka, وآخرون
منشور في: (2024-05-01)

A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
حسب: Devivasha Bordoloi, وآخرون
منشور في: (2022-11-01)

FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer
حسب: Lu Ji, وآخرون
منشور في: (2025-06-01)

Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
حسب: Iker Ausejo-Mauleon, وآخرون
منشور في: (2024-09-01)

Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
حسب: Hua-Long Zheng, وآخرون
منشور في: (2025-12-01)

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets
حسب: Dengyun Zhao, وآخرون
منشور في: (2024-05-01)

4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer
حسب: Jiaxin Yin, وآخرون
منشور في: (2024-07-01)

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers
حسب: Yueming Zhu, وآخرون
منشور في: (2024-05-01)

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
حسب: Maryam Aftabizadeh, وآخرون
منشور في: (2021-01-01)

Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
حسب: Juan Yan, وآخرون
منشور في: (2022-09-01)

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
حسب: Jiao-Bao Huang, وآخرون
منشور في: (2025-01-01)

Neoadjuvant therapy with anlotinib in a 5-year-old child with advanced papillary thyroid carcinoma: a case report
حسب: Yuan Gong, وآخرون
منشور في: (2026-05-01)

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
حسب: Heng Du, وآخرون
منشور في: (2023-11-01)

YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis
حسب: Wang Yang, وآخرون
منشور في: (2024-12-01)

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
حسب: Kun Li, وآخرون
منشور في: (2022-11-01)

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression
حسب: Weiwei Yan, وآخرون
منشور في: (2024-09-01)

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models
حسب: Zhen Chen, وآخرون
منشور في: (2024-05-01)

CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors
حسب: Tianchen Xiong, وآخرون
منشور في: (2025-08-01)

Real-world effectiveness of novel hormonal agents and docetaxel in patients with prostate cancer: A head-to-head comparison
حسب: Yuanshi Jiao, وآخرون
منشور في: (2025-04-01)

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
حسب: Shigeki Nanjo, وآخرون
منشور في: (2022-07-01)

Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS–mutant cancer models
حسب: Shihui Shen, وآخرون
منشور في: (2025-03-01)

Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response
حسب: Haipeng Tao, وآخرون
منشور في: (2025-08-01)

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy
حسب: Keisuke Shigeta, وآخرون
منشور في: (2025-07-01)

PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
حسب: Chunhua Chen, وآخرون
منشور في: (2021-04-01)

Mediator kinase inhibition reverses castration resistance of advanced prostate cancer
حسب: Jing Li, وآخرون
منشور في: (2024-05-01)

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
حسب: Mei-Kuang Chen, وآخرون
منشور في: (2025-07-01)

Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China
حسب: Qi-Chen He, وآخرون
منشور في: (2025-03-01)

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
حسب: Tara L. Hogenson, وآخرون
منشور في: (2022-11-01)

Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry
حسب: Hyesun Hyun, وآخرون
منشور في: (2025-05-01)

Identification of potent biparatopic antibodies targeting FGFR2 fusion–driven cholangiocarcinoma
حسب: Saireudee Chaturantabut, وآخرون
منشور في: (2025-04-01)

Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop
حسب: Xiangyu Zeng, وآخرون
منشور في: (2025-07-01)

First-generation and preclinical evaluation of an EphA5-targeted antibody-drug conjugate in solid tumors
حسب: Fernanda I. Staquicini, وآخرون
منشور في: (2025-07-01)

Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss in rats
حسب: Xinxia Zhu, وآخرون
منشور في: (2025-01-01)

YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation
حسب: Pritam Sadhukhan, وآخرون
منشور في: (2025-04-01)

Disruption of the KLHL37–N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models
حسب: Senfeng Xiang, وآخرون
منشور في: (2025-07-01)

Affinity-tuned mesothelin CAR T cells demonstrate enhanced targeting specificity and reduced off-tumor toxicity
حسب: Yanping Yang, وآخرون
منشور في: (2024-11-01)

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
حسب: Kyle Vaccaro, وآخرون
منشور في: (2024-05-01)